Skip to content
Search
About Us
About Us
Subscribe
News
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Clinical Trials
COVID
Dermatology
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Immunodeficiencies
Influenza
Insurance Reimbursement
Medicare
Medicines
Mental Health
Therapeutics
Vaccines
Washington Report
Women’s Disorders
Industry Insight
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Chronic Illness
COVID
Dermatology
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Immunodeficiencies
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Mental Health
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Women’s Disorders
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
News
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Clinical Trials
COVID
Dermatology
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Immunodeficiencies
Influenza
Insurance Reimbursement
Medicare
Medicines
Mental Health
Therapeutics
Vaccines
Washington Report
Women’s Disorders
Industry Insight
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Chronic Illness
COVID
Dermatology
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Immunodeficiencies
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Mental Health
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Women’s Disorders
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Home
News
All News
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Clinical Trials
COVID
Dermatology
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Immunodeficiencies
Influenza
Insurance Reimbursement
Medicare
Medicines
Mental Health
Therapeutics
Vaccines
Washington Report
Women’s Disorders
Industry Insight
All Industry Insight
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Chronic Illness
COVID
Dermatology
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Immunodeficiencies
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Mental Health
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Women’s Disorders
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Home
News
All News
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Clinical Trials
COVID
Dermatology
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Immunodeficiencies
Influenza
Insurance Reimbursement
Medicare
Medicines
Mental Health
Therapeutics
Vaccines
Washington Report
Women’s Disorders
Industry Insight
All Industry Insight
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Chronic Illness
COVID
Dermatology
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Immunodeficiencies
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Mental Health
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Women’s Disorders
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Search
Summer 2024 - Vaccines
Download Issue
Share
Up Front
Publisher's Corner
Increasing Vaccine Development Provides Hope, Despite Resistance
By Patrick M. Schmidt
Features
COVID Vaccines: What’s Available Now and What’s in the Works?
By
Diane L.M. Cook
Viruses, Variants and Vaccines: Staying Ahead of the Spread
By
Lee Warren
Myths & Facts: High Blood Pressure
By
Ronale Tucker Rhodes, MS
Update on Treating Neutropenia
By
Jim Trageser
How FDA Is Working to Accelerate Rare Disease Treatments
By
Amy Scanlin, MS
The Anti-Vaccine Movement: Where Are We Now?
By
Trudie Mitschang
BioTrends Watch
Washington Report
CDC Releases New Guide to Address Healthcare Worker Burnout
HHS Releases White Paper Focused on Preventing Drug Shortages
HHS Finalizes Rule Expanding Access to Care and Increasing Protections for Medicare Part D Plans
Reimbursement FAQs
Payment for Medications: It’s an Exacting Team Sport!
Healthcare Management
Promoting Health Equity
Industry News
New Study to Examine COVID-19 Vaccines in People with Weakened Immune Systems
New Vaccine Could Lower ‘Bad’ Cholesterol by as Much as 30 Percent
CSL Behring Adds 4 and 5 Gram Vials of ZEMAIRA
World’s First Gene Therapies Approved to Treat Sickle Cell Disease
FDA Approves Repotrectinib for Non-Small Cell Lung Cancer
Hizentra Vials to Be Discontinued and Replaced with Prefilled Syringes
Selarsdi Approved as Biosimilar to Stelara to Treat Plaque Psoriasis and Psoriatic Arthritis
FDA Grants wilate Orphan Drug Exclusivity
BioFocus
Industry Insight
The Protective Value of RSV Vaccines in Older Adults: A Deeper Dive
By Keith Berman, MPH, MBA
Patient Profile
HIV: A Patient’s Perspective
By Trudie Mitschang
Physician Profile
HIV: A Physician’s Perspective
By Trudie Mitschang
BioSources
BioResearch
Study Shows Vaccination Decision in IEI Patients Must Be Individualized
Immune Globulin and Prophylactic Antibiotics Provide Similar Efficacy in Treating Hypogammaglobulinemia Secondary to Hematological Malignancy